Filing Details

Accession Number:
0001401708-21-000225
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-11-12 16:27:37
Reporting Period:
2021-11-10
Accepted Time:
2021-11-12 16:27:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1401708 Nanostring Technologies Inc NSTG Biological Products, (No Disgnostic Substances) (2836) 200094687
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1575739 Bradley R Gray 530 Fairview Avenue N
Seattle WA 98109
President And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-11-10 12,500 $6.72 148,324 No 4 M Direct
Common Stock Disposition 2021-11-10 200 $42.93 148,124 No 4 S Direct
Common Stock Disposition 2021-11-10 4,770 $45.33 143,354 No 4 S Direct
Common Stock Disposition 2021-11-10 9,324 $45.83 134,030 No 4 S Direct
Common Stock Disposition 2021-11-10 8,204 $46.96 125,826 No 4 S Direct
Common Stock Disposition 2021-11-10 2,402 $47.90 123,424 No 4 S Direct
Common Stock Disposition 2021-11-10 100 $48.64 123,324 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2021-11-10 12,500 $6.72 12,500 $6.72
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2023-01-09 No 4 M Direct
Footnotes
  1. The sales reported by Mr. Gray were effected pursuant to a Rule 10b5-1 trading plan adopted on September 15, 2020.
  2. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $42.89 to $42.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  3. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $44.53 to $45.5150, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  4. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $45.535 to $46.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  5. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $46.54 to $47.53, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  6. The "Amount" and "Price" reported in this Column 4 reflect the aggregate number and weighted-average price, respectively, of shares sold. These shares were sold in multiple transactions at prices ranging from $47.54 to $448.52, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein.
  7. The option is subject to an early exercise provision and is immediately exercisable. 1/48th of the shares subject to such Option shall vest on each monthly anniversary of January 10, 2013.